PCR

PCR

SIREN 822980694

Active

What the register says about PCR

PCR is registered under SIREN number 822980694. Its registered office is located at 14 allée Lech Walesa, Immeuble le Cedre, 77185 Lognes. The company was founded on 01/10/2016. It declares that it operates in the Construction de maisons individuelles sector. It is currently listed as active in the national business register.

BODACC has published 9 notices concerning it, the most recent dated 26/07/2026. An account filing makes public the annual accounts submitted to the court registry: it confirms that accounting records exist and have been filed, nothing more. It says nothing about revenue, profit, or the commercial health of the company. A modification signals a declared change: management, registered office, activity, or share capital.

Identity : PCR

PCR

SIREN
822980694
Head office SIRET
82298069400027
Legal form
SAS (société par actions simplifiée)
NAF code
41.20A · Construction de maisons individuelles
Address
14 allée Lech Walesa, Immeuble le Cedre, 77185 Lognes
Creation date
10/01/2016
Category
PME
Status
Active
VAT
FR27822980694
Filing
07/26/2026
Closing
12/31/2025

Recent notices (9)

  • 07/26/2026Account depositsPCR(principal)
  • 05/04/2025Account depositsPCR(principal)
  • 10/25/2024Account depositsPCR(principal)
  • 02/29/2024Account depositsPCR(principal)
  • 11/16/2022Account depositsPCR(principal)
  • 11/15/2022Account depositsPCR(principal)

All legal notices

Web presence : PCR

The company's official website, its networks and online contact details.

Recent notices : PCR

The BODACC notices published for this company.

Relations : PCR

The relationship graph: linked notices, people and companies.

Public contracts : PCR

The public contracts won by the company.

No won public contract found for this company

FAQ & filings : PCR

Frequently asked questions and the company's filing history.

Frequently asked questions : PCR

Deposit filing history

7 dépôts de comptes enregistrés au BODACC — dernier exercice clos le 12/31/2025.